SCHEMBL6762657

SCHEMBL6762657

C[C@@H]1CC(=O)C=C2CC[C@@H]3[C@H](CC[C@@]4(C)[C@H]3CC[C@@]4(C)O)[C@H]21

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SHBG P04278 6/20 0.51
▸ PGR P06401 4/20 0.51
▸ ALDH1A1 P00352 3/20 0.51
▸ NR3C1 P04150 3/20 0.51
▸ ADRA1A P35348 2/20 0.51
▸ HTR2B P41595 1/20 0.51
▸ LMNA P02545 3/20 0.48
▸ CYP3A4 P08684 2/20 0.48
▸ ABCB11 O95342 2/20 0.48
▸ CYP2C19 P33261 2/20 0.48
▸ TSHR P16473 1/20 0.48
▸ HIF1A Q16665 1/20 0.48
▸ ESR1 P03372 1/20 0.48
▸ ADRA2A P08913 1/20 0.48
▸ SLC6A4 P31645 1/20 0.48
▸ MAPT P10636 2/20 0.47
▸ GUSB P08236 1/20 0.44
▸ POLB P06746 1/20 0.44
▸ MAPK1 P28482 1/20 0.44
▸ AR P10275 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11515555 0.89 SHBG (0.52) SHBGPGRALDH1A1NR3C1ADRA1A
SCHEMBL7702309 0.79 CYP19A1 (0.63) SHBGALDH1A1LMNATSHRMAPK1
Normethandrone SCHEMBL148631 0.79 PGR (0.73) SHBGPGRALDH1A1NR3C1ADRA1A
Normethandrone SCHEMBL23801610 0.79 PGR (0.73) SHBGPGRALDH1A1NR3C1ADRA1A
Normethandrone SCHEMBL148632 0.79 PGR (0.73) SHBGPGRALDH1A1NR3C1ADRA1A
SCHEMBL3225293 0.79 SHBG (0.65) SHBGPGRALDH1A1NR3C1LMNA
SCHEMBL5550822 0.79 SHBG (0.65) SHBGPGRALDH1A1NR3C1LMNA
SCHEMBL9948621 0.78 CYP19A1 (0.44) SHBGALDH1A1LMNACYP3A4CYP2C19
SCHEMBL23653611 0.77 PGR (0.39) SHBGPGRALDH1A1NR3C1ADRA1A
SCHEMBL16741271 0.76 SERPINA6 (0.67) SHBGPGRALDH1A1NR3C1ADRA1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1379253-A1 METHODS OF MAKING AND PHARMACEUTICAL FORMULATIONS COMPRISING 7ALPHA,11BETA-DIMETHYL-17BETA-HYDROXYESTRA-4, 14-DIEN-3-ONE AND 17 ESTERS THEREOF THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2004-01-14 — — EP disclosed
WO-2003045398-A1 METHODS OF MAKING AND PHARMACEUTICAL FORMULATIONS COMPRISING 7ALPHA, 11BETA-DIMETHY-17BETA-HYDROXYESTRA-4, 14-DIEN-3-ONE AND 17 ESTERS THEREOF THE GOVERNMENT OF THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2003-06-05 — — WO disclosed
Send feedback